CCL22 and neoplasm: Chemokine ligands CCL17 and CCL22 present in TME facilitate the infiltration and accumulation of Tregs in tumor tissue through chemokine receptor 4 (CCR4), a G protein-coupled receptor, primarily expressed on the most immunosuppressive Tregs population.